Literature DB >> 2827836

Interferon gamma in acute and subacute encephalitis.

P Lebon1, B Boutin, O Dulac, G Ponsot, M Arthuis.   

Abstract

Intrathecal synthesis of interferon gamma was shown in 14 out of 16 samples of cerebrospinal fluid collected in the first days of disease in adults, children, and newborn infants with herpes encephalitis. This synthesis was concomitant with that of interferon alpha and was switched off when the specific antibodies in the central nervous system increased. No endogenous interferon gamma was detected in 11 serum samples or 13 samples of cerebrospinal fluid collected early in the course of the disease from patients with measles encephalitis and rubella encephalitis, or in serum and cerebrospinal fluid samples from seven patients with subacute sclerosing panencephalitis. In serum collected after the 10th day after the onset of neurological symptoms interferon gamma was present at low concentrations in only three out of 11 serum specimens from patients with measles encephalitis or rubella encephalitis. Interferon gamma was present in patients with acute herpes encephalitis and there was active virus replication, but it was not present in postinfectious encephalitis. Possibly the local production of specific antibodies masks the viral antigens and switches off the induction of interferons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2827836      PMCID: PMC2544642          DOI: 10.1136/bmj.296.6614.9

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  HuIFN-gamma antiviral activity correlates with immunological reactivity in a double-monoclonal antibody radiometric assay.

Authors:  J J Sedmak; R Siebenlist; S E Grossberg
Journal:  J Interferon Res       Date:  1985

2.  Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.

Authors:  C B Wilson; J Westall; L Johnston; D B Lewis; S K Dower; A R Alpert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.

Authors:  W Fierz; B Endler; K Reske; H Wekerle; A Fontana
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

Authors:  T Collins; A J Korman; C T Wake; J M Boss; D J Kappes; W Fiers; K A Ault; M A Gimbrone; J L Strominger; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

5.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  Measles encephalomyelitis--clinical and immunologic studies.

Authors:  R T Johnson; D E Griffin; R L Hirsch; J S Wolinsky; S Roedenbeck; I Lindo de Soriano; A Vaisberg
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

7.  Diagnosis of recent rubella virus infection by demonstration of specific immunoglobulin M antibodies: comparison of solid-phase reverse immunosorbent test with sucrose density gradient centrifugation.

Authors:  G A Denoyel; A Gaspar; D Peyramond
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

8.  Inhibition of herpes simplex virus type 1-induced interferon synthesis by monoclonal antibodies against viral glycoprotein D and by lysosomotropic drugs.

Authors:  P Lebon
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

9.  Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases.

Authors:  E Dussaix; P Lebon; G Ponsot; G Huault; M Tardieu
Journal:  Acta Neurol Scand       Date:  1985-06       Impact factor: 3.209

10.  Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro.

Authors:  R L Hirsch; H S Panitch; K P Johnson
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

View more
  14 in total

Review 1.  Interoception and Inflammation in Psychiatric Disorders.

Authors:  Jonathan Savitz; Neil A Harrison
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-09

2.  Amplification and characterization of herpesvirus DNA in cerebrospinal fluid from patients with acute encephalitis.

Authors:  F Rozenberg; P Lebon
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

3.  Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin-deficient patients.

Authors:  T Mathiesen; L Hammarström; E Fridell; A Linde; G Wirsen; C I Smith; E Norrby; B Wahren
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

Review 4.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

5.  Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation.

Authors:  In-Jung Kim; Hiroko Nagasawa Beck; Pamela J Lein; Dennis Higgins
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

6.  Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.

Authors:  B Sköldenberg; E Aurelius; A Hjalmarsson; F Sabri; M Forsgren; B Andersson; A Linde; O Strannegård; M Studahl; L Hagberg; L Rosengren
Journal:  J Neurol       Date:  2005-10-17       Impact factor: 4.849

7.  Rit signaling contributes to interferon-gamma-induced dendritic retraction via p38 mitogen-activated protein kinase activation.

Authors:  Douglas A Andres; Geng-Xian Shi; Donald Bruun; Chris Barnhart; Pamela J Lein
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

8.  The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.

Authors:  Markus J Hofer; Wen Li; Sue Ling Lim; Iain L Campbell
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

9.  Subacute sclerosing panencephalitis : diagnosis and drug treatment options.

Authors:  B Anlar
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

10.  Aseptic meningitis in children: correlation between fever and interferon-gamma level.

Authors:  I Minamishima; S Ohga; E Ishii; C Miyazaki; K Hamada; K Akazawa; K Ueda
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.